<DOC>
	<DOC>NCT00479648</DOC>
	<brief_summary>Current influenza vaccines have a reduced efficacy in the elderly. This study will investigate the immunogenicity, safety and tolerability of an adjuvanted influenza vaccine in elderly participants.</brief_summary>
	<brief_title>A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged ≥ 18 to ≤ 45 OR ≥ 60 Ability to provide prevaccination venous blood sample History of clinically significant medical conditions Immunomodulative therapy Acute infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>